These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4168347)

  • 1. [On the effect of mucosa-shrinking nose drops].
    Osterwald L
    HNO; 1966 Feb; 14(2):39-41. PubMed ID: 4168347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of the preparation "Betadrin-Polfa"].
    Klonowski S; Semczuk B; Pomykalski M; Czerwonka R
    Pol Tyg Lek; 1969 Feb; 24(6):209-11. PubMed ID: 4180773
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment of rhinitis with the Dexa-Rhinospray dosage regulated aerosol and its results].
    Lindemann R
    Landarzt; 1966 Feb; 42(4):168-9. PubMed ID: 4167299
    [No Abstract]   [Full Text] [Related]  

  • 4. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
    Bielenberg J
    Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
    [No Abstract]   [Full Text] [Related]  

  • 5. A topical nasal decongestant for children.
    Neffson AH
    Eye Ear Nose Throat Mon; 1968 Mar; 47(3):121-3. PubMed ID: 4171734
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and experimental studies on a new rhinologic spray preparation (FI 6413)].
    Salami A
    Otorinolaringol Ital; 1970; 38(3):183-204. PubMed ID: 4103122
    [No Abstract]   [Full Text] [Related]  

  • 7. Relief of bronchospams by nasal inhalation therapy.
    Johnson AE
    Ann Allergy; 1970 Aug; 28(8):348-60. PubMed ID: 4106992
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined polydex with phenylephrine preparations in the treatment of patients with nasal and paranasal inflammation].
    Luchikhin LA; Grigoriev SB; Stepanenko GI
    Vestn Otorinolaringol; 1999; (3):48-9. PubMed ID: 10380613
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental studies on the effect of various mucosa decongesting nose drops].
    Knothe J; Aschoff E
    Dtsch Gesundheitsw; 1969 Dec; 24(50):2384-8. PubMed ID: 4193269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience in the use of a local vasoconstrictor, Otrivin--clinical observation by double blind, cross over method and the effect on the nasal mucosa].
    Sugiura S
    Jibiinkoka; 1971 Jan; 43(1):71-86. PubMed ID: 4099381
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of nasal obstruction.
    Taub SJ
    Eye Ear Nose Throat Mon; 1975 Jan; 54(1):33. PubMed ID: 45854
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of oral decongestants in the management of diverse types of nasal congestion.
    Fox SL
    Curr Ther Res Clin Exp; 1967 May; 9(5):247-52. PubMed ID: 4167186
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with Rhinogutt nose drops].
    Czermak L
    Dtsch Med J; 1969 Mar; 20(5):154-5. PubMed ID: 4182484
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a new oxymetazoline preparation in the treatment of nasal congestion. A multicentre trial.
    Practitioner; 1975 May; 214(1283):685-688. PubMed ID: 49890
    [No Abstract]   [Full Text] [Related]  

  • 15. Nose drops induce vasomotion in the microcirculation of the sinus mucosa of the rabbit.
    Bende M; Arfors KE; Intaglietta M
    ORL J Otorhinolaryngol Relat Spec; 1993; 55(2):110-3. PubMed ID: 7680443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical trials of Otrivin nose drops--experiences with infants and young children].
    Mizukoshi O; Imamura T; Sasaki H; Kawamoto S
    Jibiinkoka; 1969 Mar; 41(3):213-5. PubMed ID: 4181775
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rhinologic agents. 14].
    Furkert K
    Pharm Prax; 1967; 9():255-8. PubMed ID: 4183276
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sinupret in the treatment of nasal and paranasal sinus diseases].
    Poliakova TS; Vladimirova VV
    Vestn Otorinolaringol; 2001; (2):50-1. PubMed ID: 11338563
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with the vasoconstrictor action of H 1032 on the nasal mucosa].
    Carta F
    Arch Ital Otol Rinol Laringol Patol Cervicofacc; 1967; 78(4):510-9. PubMed ID: 4180004
    [No Abstract]   [Full Text] [Related]  

  • 20. Do topical nasal decongestants affect polyps?
    Johansson L; Oberg D; Melén I; Bende M
    Acta Otolaryngol; 2006 Mar; 126(3):288-90. PubMed ID: 16618656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.